[
  {
    "ts": null,
    "headline": "Better Income Stock: Pfizer or Altria Group?",
    "summary": "High-yield dividend stocks often catch investors' attention -- and for good reason.  When established companies maintain larger-than-average dividend payments, they can provide both substantial current income and the potential for long-term appreciation.  Other times, they signal legitimate concerns about a company's ability to maintain its dividend payments in the face of deteriorating business conditions.",
    "url": "https://finnhub.io/api/news?id=dfaa369d90c45a51465d1924f3206e570a03b34ea074ed98d519bf637e38274e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735134300,
      "headline": "Better Income Stock: Pfizer or Altria Group?",
      "id": 132161332,
      "image": "https://g.foolcdn.com/editorial/images/802073/dividends-alternative.jpg",
      "related": "MO",
      "source": "Yahoo",
      "summary": "High-yield dividend stocks often catch investors' attention -- and for good reason.  When established companies maintain larger-than-average dividend payments, they can provide both substantial current income and the potential for long-term appreciation.  Other times, they signal legitimate concerns about a company's ability to maintain its dividend payments in the face of deteriorating business conditions.",
      "url": "https://finnhub.io/api/news?id=dfaa369d90c45a51465d1924f3206e570a03b34ea074ed98d519bf637e38274e"
    }
  }
]